Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AX Other antivirals
J05AX25 Baloxavir marboxil
D11021 Baloxavir marboxil (JAN/USAN/INN) <JP/US>
USP drug classification [BR:br08302]
Antivirals
Anti-influenza Agents
Baloxavir Marboxil
D11021 Baloxavir marboxil (JAN/USAN/INN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D11021 Baloxavir marboxil (JAN/USAN/INN)
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02962 Baloxavir
D11021 Baloxavir marboxil
Drug classes [BR:br08332]
Antiviral
DG03029 Anti-influenza virus agent
D11021 Baloxavir marboxil
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
Other inhibitor
D11021 Baloxavir marboxil (JAN/USAN/INN) <JP/US>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D11021
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D11021
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D11021
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D11021
Drug groups [BR:br08330]
Antiviral
DG03029 Anti-influenza virus agent
DG02962 Baloxavir